Not all cancer patients need chemo — Ataraxis AI raised $20M to personalize treatment
The New York-based startup is focused on using AI to accurately predict not only if a patient has cancer, but also what their ...
Business Wire3d
Ataraxis AI to Transform Precision Medicine in Cancer Care with $20.4 Million Series A
Ataraxis AI, the leading AI precision medicine company, today announced its $20.4 million Series A financing led by AIX ...
Precision Medicine Online3d
Precision Medicine Startup Ataraxis AI Nabs $20.4M in Series Financing
Ataraxis AI will use the new funding to bring to market its first offering, Ataraxis Breast, an AI-native prognostic/predictive platform for breast cancer.
Yahoo Finance4d
Not all cancer patients need chemo. Ataraxis AI raised $20M to fix that.
That's the problem Ataraxis AI is trying to solve. The New York-based startup is focused on using AI to accurately predict not only if a patient has cancer, but also what their cancer outcome ...
Morningstar4d
Ataraxis AI to Transform Precision Medicine in Cancer Care with $20.4 Million Series A
With new backing from AIX Ventures, Peter Thiel, and healthcare and AI pioneers, Ataraxis AI is positioned to rapidly bring its first offering, Ataraxis Breast, to market Ataraxis AI, the leading ...